Delivery Order SPE2DR25D3012-SPE2DR26F4C9R
- Not listed
- The Defense Logistics Agency awarded a $1,149.00 delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with an ultimate completion date of December 4, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation, indicating the contract was competitively awarded. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5g packages, with a ceiling value of $1,296.00. This is a firm fixed-price delivery order with an ultimate completion date of December 3, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order under a larger contract vehicle and requires the...
- The Defense Logistics Agency awarded a $1,474.44 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packages of 5 grams. The contract, which was competitively awarded with no set-aside designation, has an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,296.00 to AmerisourceBergen Drug Corp for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and was competitively awarded without set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate office and serves as...
- The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract, indicating it falls under a larger indefinite delivery vehicle. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages, valued at $1,301.87, with an ultimate completion date of November 18, 2025. This competitively awarded, non-set-aside contract is a firm fixed price delivery order, and AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The award was executed on November 17, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,765.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. The contract represents a firm fixed price delivery order with no set-aside designation, reflecting competitive award terms. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility by September 17, 2025. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,070.82 to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Testosterone 1% (50 mg/5g) in unit dose packages of 5 grams. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 5, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Testosterone 1% (50 mg/5 g) in unit-dose 5-gram packages, with a ceiling value of $1,408.87. The contract is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, awarded on December 1, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and represents a...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C9RDelivery Order
The Defense Logistics Agency awarded a $1,296.00 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with an ultimate completion date of December 8, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying pharmaceuticals and medical supplies to support military and veteran healthcare systems. The company's federal contract portfolio encompasses a comprehensive range of therapeutic products including specialty medications, vaccines, and medical devices, positioning it to fulfill diverse medical supply requirements across the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 12/4/25 |